Antidepressant News and Research

RSS

Antidepressants are medicines that treat depression. Your doctor can prescribe them for you. They can improve your mood, sleep, appetite and concentration. It may take several weeks for them to help. There are several types of antidepressants. You and your doctor may have to try several before finding what works best for you.

TAU researchers discover gene that may predict human responses to specific antidepressants

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants, but they don't work for everyone. What's more, patients must often try several different SSRI medications, each with a different set of side effects, before finding one that is effective.

9 Dec 2013

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

The majority of epilepsy patients who have brain surgery to treat their disorder are satisfied with the results in reducing epilepsy-related seizures and improving their psychological and social well-being.

9 Dec 2013

Researchers investigate effect of epilepsy surgery on patients lives

Resective surgery is an effective treatment for dug-resistant epilepsy. To investigate the effect of epilepsy surgery on patients lives, researchers from the Comprehensive Epilepsy Program at the Henry Ford Hospital in Detroit conducted a long-term retrospective follow up of surgical patients and correlated post-surgical psychosocial outcomes with seizure outcome and brain area surgically treated.

9 Dec 2013

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

A study published in the current issue of Psychotherapy and Psychosomatics has examined the correlation between polyunsaturated fatty acids in the blood and the risk of post-traumatic stress disorder.

6 Dec 2013

Bipolar-specific disease management gives good returns

Diagnostic-specific management of bipolar II disorder is associated with significant clinical improvements, show findings that support the need for greater recognition of the condition.

4 Dec 2013

San Diego School of Medicine receives grant to provide professional training to senior drivers

For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.

27 Nov 2013

Viewpoints: Senate should reconsider treaty on protections for people with disabilities; HHS treading wrong way on payments for bone marrow donors

About a year ago the Senate fell five votes short of ratifying an international treaty that would improve protections for the disabled. It was an ignoble spectacle as the opponents rebuffed Bob Dole, a former colleague and disabled veteran, who came to the Senate floor to lobby for it.

26 Nov 2013

Researchers analyze effects of MXE drug usage

Researchers from Sweden have attempted to create an understanding to the subjective effects from use of Methoxetamine (MXE), a drug belonging to a class known as "legal highs" or "research chemicals," and available for purchase on the Internet.

26 Nov 2013

Antidepressants in pregnancy do not cause autism, study finds

New research cannot establish a close connection between the use of antidepressant medication - the so-called SSRIs - during the course of pregnancy and the risk of having a child with autism.

25 Nov 2013

Enhancing the NMDA glutamate receptor causes antidepressant-like effects

Thirteen years ago, an article in this journal first reported that the anesthetic medication, ketamine, showed evidence of producing rapid antidepressant effects in depressed patients who had not responded to prior treatments. Ketamine works by blocking one of the targets for the neurotransmitter glutamate in the brain, the N-methyl-D-aspartate (NMDA) glutamate receptor.

20 Nov 2013

mTOR protein: A key mediator of antidepressant effects of ketamine

Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified.

20 Nov 2013

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Women with depression in the perinatal period experience a high degree of conflict in deciding whether and how to treat their depression, but strongly prefer treatments other than antidepressant medications, reports a study in the November Journal of Psychiatric Practice®. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Nov 2013

Depression link to Parkinson’s risk bolstered

A large retrospective study supports the notion that depression may be an independent risk factor for Parkinson’s disease.

14 Nov 2013

New view can give scientists better understanding of how antidepressants work in human brain

Research from Oregon Health & Science University's Vollum Institute, published in the current issue of Nature, is giving scientists a never-before-seen view of how nerve cells communicate with each other.

13 Nov 2013

Research: New mechanisms and areas of brain linked with anxiety and depression

Research released today reveals new mechanisms and areas of the brain associated with anxiety and depression, presenting possible targets to understand and treat these debilitating mental illnesses.

12 Nov 2013

Researchers identify critical mechanism to improve survival and behavior of new brain cells

A specialized type of brain cell that tamps down stem cell activity ironically, perhaps, encourages the survival of the stem cells' progeny, Johns Hopkins researchers report.

11 Nov 2013

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

The Brain & Behavior Research Foundation (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of Dr. Jeffrey Borenstein, President & CEO, has announced the latest recipients of its NARSAD Distinguished Investigator Grants.

8 Nov 2013

Interactive multimedia computer program does not improve mental health in depressed patients

Among depressed patients evaluated in a primary care setting, use of an interactive multimedia computer program immediately prior to a primary care visit resulted in the increased receipt of antidepressant prescription recommendation, mental health referral, or both; however, it did not result in improvement in mental health at 12-week follow-up, according to a study in the November 6 issue of JAMA.

6 Nov 2013

First-episode type predicts morbidity, disease course in bipolar disorder

Study findings suggest that the type of first episode in patients with bipolar disorder can predict the type and degree of future morbidity, as well as the disease course.

5 Nov 2013

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

e-Therapeutics plc announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder.

31 Oct 2013

Antidepressant News and Research

Further Reading

TAU researchers discover gene that may predict human responses to specific antidepressants

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

Researchers investigate effect of epilepsy surgery on patients lives

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

Bipolar-specific disease management gives good returns

San Diego School of Medicine receives grant to provide professional training to senior drivers

Viewpoints: Senate should reconsider treaty on protections for people with disabilities; HHS treading wrong way on payments for bone marrow donors

Researchers analyze effects of MXE drug usage

Antidepressants in pregnancy do not cause autism, study finds

Enhancing the NMDA glutamate receptor causes antidepressant-like effects

mTOR protein: A key mediator of antidepressant effects of ketamine

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Depression link to Parkinson’s risk bolstered

New view can give scientists better understanding of how antidepressants work in human brain

Research: New mechanisms and areas of brain linked with anxiety and depression

Researchers identify critical mechanism to improve survival and behavior of new brain cells

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

Interactive multimedia computer program does not improve mental health in depressed patients

First-episode type predicts morbidity, disease course in bipolar disorder

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News